Shen-Shuai-Ling Formulation Attenuates Renal Interstitial Fibrosis in Chronic Kidney Disease by Regulating SHH-Gli1 Signaling Pathway

Figure 3

Histopathological changes in each group. 1: Sham group; 2: Model group; 3: SSLF group; 4: CPN group; 5: C + S group (HE staining, ×200).